Phase 1 Safety Study of ALRN-5281 in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The primary objective of this study is to evaluate the safety and tolerability of a single dose of ALRN-5281 administered by subcutaneous injection to healthy adult volunteers.
Epistemonikos ID: af2de734e7a0a7cdeddfc42c302abcf27cee2cd2
First added on: May 11, 2024